Predictors identified for losses to follow-up among HIV-seropositive patients

Journal of Clinical Epidemiology

Volumn 59, Issue 8, 2006, Pages

  Lanoy, Emilie ^a   Mary Krause, Murielle ^a   Tattevin, Pierre ^b   Dray Spira, Rosemary ^a   Duvivier, Claudine ^c   Fischer, Patricia ^d   Obadia, Yolande ^a   Lert, France ^a   Costagliola, Dominique ^a   the Clinical Epidemiology Group of the French Hospital Database on HIV infection, ^e  

^a INSERM   (France)

^b PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^e Antenne d'immuno onco hématologie ^*

Author keywords

Bias; Clinical management; Cohort data; HIV infection; Loss to follow up

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA BASE; DEATH; DEMOGRAPHY; FOLLOW UP; FRANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMIGRANT; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; VIRUS LOAD; WESTERN HEMISPHERE;

EID: 33745891823     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2005.11.024     Document Type: Article

References (27)

1. Friis-Moller N., Weber R., D'Arminio Monforte A., El-Sadr W., Reiss P., Dabis F., et al. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 349 (2003) 1993-2003
2. Bozette S.A., Ake C.F., Tam H.K., Chang S.W., Louis T.A., et al. Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. N Engl J Med 348 (2000) 702-710
3. May M., Porter K., Sterne J., Royston P., and Egger M. Prognostic model for HIV-1 disease progression in patients starting antiretroviral therapy was validated using independent data. J Clin Epidemiol 58 10 (2005) 1033-1041
4. Anglaret X., Toure S., Gourvellec G., Tchehy A., Zio L., Zaho M., et al. Impact of vital status investigation procedures on estimates of survival in cohorts of HIV-infected patients from Sub-Saharan Africa. J Acquir Immune Defic Syndr 35 3 (2004) 320-323
5. Cottler L.B., Compton W.M., Ben-Abdallah A., Horne M., and Claverie D. Achieving a 96.6 percent follow-up rate in a longitudinal study of drug abusers. Drug Alcohol Depend 41 3 (1996) 209-217
6. Twisk J., and de Vente W. Attrition in longitudinal studies. How to deal with missing data. J Clin Epidemiol 55 4 (2002) 329-337
7. Palella Jr. F.J., Delaney K.M., Moorman A.C., Loveless M.O., Fuhrer J., Satten G.A., et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 338 (1998) 853-860
8. Mary-Krause M., Cotte L., Simon A., Partisani M., and Costagliola D. Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men. AIDS 17 17 (2003) 2479-2486
9. Ledergerber B., Telenti A., and Egger M. Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: prospective cohort study. Swiss HIV Cohort Study. BMJ 319 7201 (1999) 23-24
10. Mocroft A., Ledergerber B., Katlama C., Kirk O., Reiss P., d'Arminio Monforte A., et al. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet 362 9377 (2003) 22-29
11. Herida M., Mary-Krause M., Kaphan R., Cadranel J., Poizot-Martin I., Rabaud C., Plaisance N., Tissot-Dupont H., Boue F., Lang J.M., and Costagliola D. Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. J Clin Oncol 21 18 (2003) 3447-3453
12. Tassié J.M., Gasnault J., Bentata M., Deloumeaux J., Boué F., Billaud E., et al. Survival improvement of AIDS-related progressive multifocal leukoencephalopathy in the era of protease inhibitors. AIDS 13 (1999) 1881-1887
13. Lert F, Obadia Y et l'équipe de l'enquête VESPA. Comment vit-on en France avec le VIH/SIDA? INED Populat Soc 2004;406:1-5.
14. Ancelle-Park R.A. Expanded European AIDS definition. Lancet 341 (1993) 441
15. Prise en charge thérapeutique des personnes infectées par le VIH. Mise à jour 2000. recommandations du groupe d'experts sous la direction du Pr JF Delfraissy. Ed. Flammarion Médecine-Sciences; 2000.
16. Cohen C., Iwane M., Palensky J., Levin D., Meagher K., Frost K., et al. A National HIV Community Cohort': Design, Baseline, and Follow-up of the AmFAR Observational Database. J Clin Epidemiol 51 9 (1998) 779-793
17. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine. Institut National de la Santé et de la Recherche Médicale Unité U593. Rapport d'activités no. 16 2004 Available at: http://www.isped.u-bordeaux2.fr/RECHERCHE/GECSA/Rapport%20GECSA%202003.p df.
18. Hessol N., Schneider M., Greenblatt R., Bacon M., Barranday Y., Holman S., et al. Retention of women enroled in a prospective study of Human Immunodeficiency Virus infection: Impact of race, unstable housing, and use of Human Immunodeficiency Virus therapy. AJE 154 6 (2001) 563-573
19. Simon G. Les migrations internationales. INED Populat Soc 382 (2002) 1-4
20. Bernillon P., Lièvre L., Pillonel J., Laporte A., Costagliola D., and The Clinical Epidemiology Group form CISIH. Record-linkage between two anonymous databases for a capture-recapture estimation of underreporting of AIDS cases. Int J Epidemiol 29 (2000) 168-174
21. Lewden C., Jougla E., Costagliola D., Pavillon G., Morlat P., Salmon D., et al. Comparaison de trois systèmes de recueil des cas de décès d'adultes infectés par le virus de l'immunodéficience humaine en France en 2000. Rev Epidemiol Sante Publique 52 (2004) 1S127
22. Lewden C., Salmon D., Morlat P., Bevilacqua S., Jougla E., Bonnet F., et al. Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS. Int J Epidemiol 34 (2005) 121-130
23. Ioannidis J.P., Bassett R., Hughes M.D., Volberding P.A., Sacks H.S., and Lau J. Predictors and impact of patients lost to follow-up in a long-term randomized trial of immediate versus deferred antiretroviral treatment. J Acquir Immune Defic Syndr Hum Retrovirol 16 1 (1997) 22-30
24. Bouhnik A.D., Chesney M., Carrieri P., Gallais H., Moreau J., Moatti J.P., Obadia Y., Spire B., and the MANIF 2000 Study Group. Nonadherence among HIV-infected injecting durg users: the impact of social instability. JAIDS 31 (2002) S149-S153
25. Mobilité par temps de crise. INED Populat Soc 279 (1993) 1-4
26. Repenser la politique de lutte contre le VIH/SIDA dans les départements d'outre-mer. Rapport suivi de recommandations du Conseil National du Sida, 11 mars 2003.
27. Savignoni A., Lot F., Pillonel J., et al. InVS. Unité Maladies-Infectieuses, Saint-Maurice. Situation du SIDA dans la population étrangère domiciliée en France depuis le début de l'épidémie jusqu'en juin 1998. BEH 99 (1999) 113-114